TherapeuticsMD (TXMD) Current Assets (2010 - 2026)

TherapeuticsMD's Current Assets history runs 17 years deep, the most recent figure standing at $15.3 million for Q1 2026.

• Quarterly Current Assets rose 21.99% year-over-year to $15.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.3 million (up 21.99% YoY) and the FY2025 annual result came in at $14.4 million, up 17.83% from the prior year.
• Current Assets was $15.3 million for Q1 2026 at TherapeuticsMD, up from $14.4 million in the prior quarter.
• Across five years, Current Assets topped out at $98.6 million in Q2 2022 and bottomed at $11.5 million in Q1 2024.
• A 5-year average of $30.4 million and a median of $14.5 million in 2025 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2023 — Current Assets sank 80.11% — and 2026, when it increased 21.99%.
• TherapeuticsMD's Current Assets stood at $55.4 million in 2022, then slumped by 78.69% to $11.8 million in 2023, then climbed by 3.93% to $12.3 million in 2024, then gained by 17.83% to $14.4 million in 2025, then rose by 5.66% to $15.3 million in 2026.
• Business Quant data shows TXMD's Current Assets at $15.3 million in Q1 2026, $14.4 million in Q4 2025, and $14.5 million in Q3 2025.